Omics! Omics!

A computational biologist's personal views on new technologies & publications on genomics & proteomics and their impact on drug discovery

Thursday, April 30, 2026

If My Agent Can't See Your Catalog, Will It Exist Much Longer?

›
Another edition of my dabbling with AI.  Somewhat like what I reported before - a customer asked if Ginkgo Cloud Lab's Echo-MS option ...
Saturday, April 25, 2026

Crossing the Vibicon

›
Vibe coding - solving problems by extended conversation with a machine learning program rather than writing the code yourself - is all the r...
Wednesday, April 22, 2026

Invivoscribe PrepQuant: Streamlining Clinical DNA Extraction

›
The liquid biopsy space continues to grow and heat up - just this week Roche's Foundation Medicine unit announced the acquisition of Min...
1 comment:
Friday, April 17, 2026

AGBT Agriculture 2026: A Few Paragraphs on Graphs

›
AGBT Agriculture was a really nice meeting - lovely venue in the Arizona desert, a meeting size that you felt you could (but weren't com...
Sunday, April 12, 2026

Flowers: A Matter of Timing

›
I'm headed over to AGBT Agriculture tomorrow, after getting to Phoenix ahead of time to check out some sights.  The Desert Botanical Gar...
1 comment:
Tuesday, March 31, 2026

A Wish For Snail-Inspired Tulips

›
About a year ago we took a family vacation to the Netherlands with a prime goal to see tulips - and tulips we did see!  Even a rainy day (wh...
Monday, March 30, 2026

icon16: Precise Amplification for All!

›
I've loved the n6tec icon96 instrument since they first tipped me about it several years back.  The idea of running 96 independent PCRs ...
›
Home
View web version

About Me

My photo
Keith Robison
Dr. Robison spent 10 years at Millennium Pharmaceuticals working with various genomics & proteomics technologies & working on multiple teams attempting to apply these throughout the drug discovery process. He spent 2 years at Codon Devices working on a variety of protein & metabolic engineering projects as well as monitoring a high-throughput gene synthesis facility. After a brief bit of consulting, he rejoined the cancer drug discovery field at Infinity Pharmaceuticals in May 2009. In September 2011 he joined Warp Drive Bio, a startup applying genomics to natural product drug discovery. In February 2019 he joined Ginkgo Bioworks, a synthetic biology company. Other recurring characters in this blog are his late loyal Shih Tzu Amanda, his current Shih Poo Lily and his now adult son alias TNG (The Next Generation). Dr. Robison can be reached via his Gmail account, keith.e.robison@gmail.com You can also follow him on Twitter as @OmicsOmicsBlog.
View my complete profile
Powered by Blogger.